EP3307267
Meðferð við heila- og mænusiggi
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
9.6.2017EP published:
10.4.2019EP application number:
17735004.8
EP translation filed:
18.6.2019Grant published:
15.8.2019EPO information:
European Patent Register
Max expiry date:
8.6.2037Expiry date:
8.6.2024
Title:
MULTIPLE SCLEROSIS TREATMENT
Timeline
Today
9.6.2017EP application
10.4.2019EP Publication
18.6.2019Translation submitted
15.8.2019Registration published
8.6.2024Expires
Owner
Name:
Oryzon Genomics, S.A.Address:
Carrera de San Jérónimo 15, 2nd floor, 28014, Madrid, ES
Inventor
Name:
MAES, TamaraAddress:
Cornellà De Llobregat, ES
Name:
MASCARÓ CRUSAT, CristinaAddress:
Cornellà De Llobregat, ES
Name:
ROTLLANT POZO, DavidAddress:
Cornellà De Llobregat, ES
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
PCT/EP2016/063368Date:
10.6.2016Country:
WO
Classification
Categories:
A61K 31/42
Annual fees
Number
Paid
Expires
Payer
Number: 3
Paid: 24.6.2019
Expires: 8.6.2020
Payer: Tego ehf.
Number: 4
Paid: 23.6.2020
Expires: 8.6.2021
Payer: Árnason Faktor ehf.
Number: 5
Paid: 24.6.2021
Expires: 8.6.2022
Payer: Árnason Faktor ehf.
Number: 6
Paid: 29.10.2022
Expires: 8.6.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 22.6.2023
Expires: 8.6.2024
Payer: Árnason Faktor ehf.